Cargando…

Efficacy of a Novel Exoskeletal Robot for Locomotor Rehabilitation in Stroke Patients: A Multi-center, Non-inferiority, Randomized Controlled Trial

Objective: To investigate the efficacy and safety of a novel lower-limb exoskeletal robot, BEAR-H1 (Shenzhen Milebot Robot Technology), in the locomotor function of subacute stroke patients. Methods: The present study was approved by the ethical committee of the First Affiliated Hospital of Nanjing...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yongqiang, Fan, Tao, Qi, Qi, Wang, Jun, Qiu, Huaide, Zhang, Lingye, Wu, Xixi, Ye, Jing, Chen, Gong, Long, Jianjun, Wang, Yulong, Huang, Guozhi, Li, Jianan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419710/
https://www.ncbi.nlm.nih.gov/pubmed/34497506
http://dx.doi.org/10.3389/fnagi.2021.706569
_version_ 1783748807618461696
author Li, Yongqiang
Fan, Tao
Qi, Qi
Wang, Jun
Qiu, Huaide
Zhang, Lingye
Wu, Xixi
Ye, Jing
Chen, Gong
Long, Jianjun
Wang, Yulong
Huang, Guozhi
Li, Jianan
author_facet Li, Yongqiang
Fan, Tao
Qi, Qi
Wang, Jun
Qiu, Huaide
Zhang, Lingye
Wu, Xixi
Ye, Jing
Chen, Gong
Long, Jianjun
Wang, Yulong
Huang, Guozhi
Li, Jianan
author_sort Li, Yongqiang
collection PubMed
description Objective: To investigate the efficacy and safety of a novel lower-limb exoskeletal robot, BEAR-H1 (Shenzhen Milebot Robot Technology), in the locomotor function of subacute stroke patients. Methods: The present study was approved by the ethical committee of the First Affiliated Hospital of Nanjing Medical University (No. 2019-MD-43), and registration was recorded on the Chinese Clinical Trial Registry with a unique identifier: ChiCTR2100044475. A total of 130 patients within 6 months of stroke were randomly divided into two groups: the robot group and the control group. The control group received routine training for walking, while in the robot group, BEAR-H1 lower-limb exoskeletal robot was used for locomotor training. Both groups received two sessions daily, 5 days a week for 4 weeks consecutively. Each session lasted 30 min. Before treatment, after treatment for 2 weeks, and 4 weeks, the patients were assessed based on the 6-minute walking test (6MWT), functional ambulation scale (FAC), Fugl-Meyer assessment lower-limb subscale (FMA-LE), and Vicon gait analysis. Results: After a 4-week intervention, the results of 6MWT, FMA-LE, FAC, cadence, and gait cycle in the two groups significantly improved (P < 0.05), but there was no significant difference between the two groups (P > 0.05). The ratio of stance phase to that of swing phase, swing phase symmetry ratio (SPSR), and step length symmetry ratio (SLSR) was not significantly improved after 4 weeks of training in both the groups. Further analyses revealed that the robot group exhibited potential benefits, as the point estimates of 6MWT and Δ6MWT (post-pre) at 4 weeks were higher than those in the control group. Additionally, within-group comparison showed that patients in the robot group had a significant improvement in 6MWT earlier than their counterparts in the control group. Conclusions: The rehabilitation robot in this study could improve the locomotor function of stroke patients; however, its effect was no better than conventional locomotor training.
format Online
Article
Text
id pubmed-8419710
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84197102021-09-07 Efficacy of a Novel Exoskeletal Robot for Locomotor Rehabilitation in Stroke Patients: A Multi-center, Non-inferiority, Randomized Controlled Trial Li, Yongqiang Fan, Tao Qi, Qi Wang, Jun Qiu, Huaide Zhang, Lingye Wu, Xixi Ye, Jing Chen, Gong Long, Jianjun Wang, Yulong Huang, Guozhi Li, Jianan Front Aging Neurosci Neuroscience Objective: To investigate the efficacy and safety of a novel lower-limb exoskeletal robot, BEAR-H1 (Shenzhen Milebot Robot Technology), in the locomotor function of subacute stroke patients. Methods: The present study was approved by the ethical committee of the First Affiliated Hospital of Nanjing Medical University (No. 2019-MD-43), and registration was recorded on the Chinese Clinical Trial Registry with a unique identifier: ChiCTR2100044475. A total of 130 patients within 6 months of stroke were randomly divided into two groups: the robot group and the control group. The control group received routine training for walking, while in the robot group, BEAR-H1 lower-limb exoskeletal robot was used for locomotor training. Both groups received two sessions daily, 5 days a week for 4 weeks consecutively. Each session lasted 30 min. Before treatment, after treatment for 2 weeks, and 4 weeks, the patients were assessed based on the 6-minute walking test (6MWT), functional ambulation scale (FAC), Fugl-Meyer assessment lower-limb subscale (FMA-LE), and Vicon gait analysis. Results: After a 4-week intervention, the results of 6MWT, FMA-LE, FAC, cadence, and gait cycle in the two groups significantly improved (P < 0.05), but there was no significant difference between the two groups (P > 0.05). The ratio of stance phase to that of swing phase, swing phase symmetry ratio (SPSR), and step length symmetry ratio (SLSR) was not significantly improved after 4 weeks of training in both the groups. Further analyses revealed that the robot group exhibited potential benefits, as the point estimates of 6MWT and Δ6MWT (post-pre) at 4 weeks were higher than those in the control group. Additionally, within-group comparison showed that patients in the robot group had a significant improvement in 6MWT earlier than their counterparts in the control group. Conclusions: The rehabilitation robot in this study could improve the locomotor function of stroke patients; however, its effect was no better than conventional locomotor training. Frontiers Media S.A. 2021-08-23 /pmc/articles/PMC8419710/ /pubmed/34497506 http://dx.doi.org/10.3389/fnagi.2021.706569 Text en Copyright © 2021 Li, Fan, Qi, Wang, Qiu, Zhang, Wu, Ye, Chen, Long, Wang, Huang and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Li, Yongqiang
Fan, Tao
Qi, Qi
Wang, Jun
Qiu, Huaide
Zhang, Lingye
Wu, Xixi
Ye, Jing
Chen, Gong
Long, Jianjun
Wang, Yulong
Huang, Guozhi
Li, Jianan
Efficacy of a Novel Exoskeletal Robot for Locomotor Rehabilitation in Stroke Patients: A Multi-center, Non-inferiority, Randomized Controlled Trial
title Efficacy of a Novel Exoskeletal Robot for Locomotor Rehabilitation in Stroke Patients: A Multi-center, Non-inferiority, Randomized Controlled Trial
title_full Efficacy of a Novel Exoskeletal Robot for Locomotor Rehabilitation in Stroke Patients: A Multi-center, Non-inferiority, Randomized Controlled Trial
title_fullStr Efficacy of a Novel Exoskeletal Robot for Locomotor Rehabilitation in Stroke Patients: A Multi-center, Non-inferiority, Randomized Controlled Trial
title_full_unstemmed Efficacy of a Novel Exoskeletal Robot for Locomotor Rehabilitation in Stroke Patients: A Multi-center, Non-inferiority, Randomized Controlled Trial
title_short Efficacy of a Novel Exoskeletal Robot for Locomotor Rehabilitation in Stroke Patients: A Multi-center, Non-inferiority, Randomized Controlled Trial
title_sort efficacy of a novel exoskeletal robot for locomotor rehabilitation in stroke patients: a multi-center, non-inferiority, randomized controlled trial
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419710/
https://www.ncbi.nlm.nih.gov/pubmed/34497506
http://dx.doi.org/10.3389/fnagi.2021.706569
work_keys_str_mv AT liyongqiang efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial
AT fantao efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial
AT qiqi efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial
AT wangjun efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial
AT qiuhuaide efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial
AT zhanglingye efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial
AT wuxixi efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial
AT yejing efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial
AT chengong efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial
AT longjianjun efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial
AT wangyulong efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial
AT huangguozhi efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial
AT lijianan efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial